What was recalled
The U.S. Food and Drug Administration (FDA) has announced a Class II recall involving specific software used in critical healthcare monitoring systems. The product at the center of this notice is PORTRAIT CORE SERVICES SOFTWARE, version 1.0.5, manufactured by GE Medical Systems Information Technologies Inc. This is not a physical device you might find on a store shelf, but rather a sophisticated piece of digital infrastructure designed to manage and display patient data across medical facilities. The official recall reference number for this action is 5697353, which you may need when contacting the manufacturer or regulatory bodies for verification.
This software update was distributed through a specific Global Trade Item Number (GTIN) of 00195278364838. Because this is specialized medical technology, the recall targets very precise serial numbers rather than an entire production line indiscriminately. The affected units include those with serial identifiers SUC23080050TA, SUD22470001TA, SUD22420001TA, SUD22470010TA, SUD23390001TA, SUD23390003TA, SUD23390004TA, SUD23390009TA, SUD23390010TA, SUD22470009TA, SUD22470003TA, SUD22470004TA, SUD22470005TA, SUD23390005TA, and SUD22280002TA. If you are a healthcare administrator or technical staff member, you must cross-reference these exact codes against your inventory to determine if your facility is impacted.
The distribution pattern for this software indicates that it was sold not only within the United States but also internationally. Domestic sales included units distributed in the states of Michigan (MI), New York (NY), and Wisconsin (WI). Beyond U.S. borders, the product reached markets in Australia, the Czech Republic, Finland, Germany, Italy, the Netherlands, Qatar, Saudi Arabia, Switzerland, the United Arab Emirates, and the United Kingdom. This global reach means that healthcare providers in any of these regions should review their equipment logs carefully.
The recall was officially dated July 20, 2026. While the FDA classifies this as a Class II recall—indicating a temporary or reversible health hazard that is not likely to cause serious adverse health consequences—the specificity of the software version and serial numbers highlights the importance of precise identification. GE Medical Systems has initiated this process to address potential failures in the PORTRAIT system’s ability to maintain consistent patient monitoring and alarm settings. Understanding exactly which units are affected is the first critical step in ensuring that clinical operations remain uninterrupted and safe for patients.
The hazard, explained
At the heart of this recall is a specific software issue within the PORTRAIT CORE SERVICES SOFTWARE V1.0.5. To understand why this matters, it helps to look at how modern hospital monitoring systems work. These systems rely on a central "hub" that collects data from individual patient monitors and displays it on a "central viewer," which is typically located at a nursing station or control room. This setup allows healthcare providers to keep an eye on multiple patients simultaneously without being physically present at every bedside. The software in question acts as a critical component of this communication network, ensuring that vital signs and alarm signals are transmitted accurately and consistently.
The problem identified by the FDA arises when this specific version of the software is installed or updated. There are two distinct but related failures that can occur. First, the software may experience a loss of patient monitoring at both the Hub and the Central Viewer. In practical terms, this means that the screens where nurses and doctors track heart rates, oxygen levels, and other vital signs could suddenly go blank, freeze, or fail to update with new data. This is not merely an inconvenience; it is a complete break in the chain of observation. If a patient’s condition changes rapidly—a sudden drop in blood pressure or an irregular heartbeat—the central monitoring station will not receive that information, leaving staff unaware of a potentially life-threatening situation until they physically check on the patient.
The second part of the hazard involves the system's alarm settings. Following an update to this software version, all alarm configurations may be reset to their original factory defaults. This is particularly dangerous because healthcare providers carefully customize these alarms for each individual patient and care area. For example, a post-surgical patient might have different alert thresholds than a stable outpatient, or specific areas of a hospital might require louder or more frequent alerts. When the software resets these settings, it ignores those critical, life-saving customizations. If a patient’s vitals go outside their specific safe range, the alarm may not sound at all, or it may sound in a way that is easily ignored because it lacks the urgency required for that specific clinical context.
When you combine these two failures—the loss of visual monitoring data and the potential silence or misconfiguration of alarms—you create a scenario where early warning signs are completely missed. In critical care environments, seconds count. A delay in detecting an adverse event because the central system has failed to relay information can lead to delayed intervention, increased patient harm, or even fatality. This is why the FDA has classified this as a Class II recall, indicating that while the situation may not be immediately life-threatening for every single instance, it poses a serious risk to health if left unaddressed.
Who is most at risk
When we talk about who is "at risk" in this specific recall, it is helpful to look at the situation from two different angles: the people who are directly dependent on the technology’s reliability, and the patients whose medical care could be disrupted. The recalled item is the PORTRAIT CORE SERVICES SOFTWARE V1.0.5, manufactured by GE Medical Systems Information Technologies Inc. This is not a consumer gadget like a smartwatch or a home blood pressure monitor that you might buy at a pharmacy. It is specialized, critical-care infrastructure used in professional medical settings. Therefore, the primary group at risk consists of patients currently being monitored within healthcare facilities that utilize this specific software version.
The hazard described in the FDA recall notice is significant because it involves both the loss of patient monitoring data and the resetting of alarm settings to factory defaults. For a general audience, "alarm settings" might sound like an inconvenience, akin to your home security system forgetting its code. However, in a hospital or intensive care unit, these alarms are the lifeline connecting a patient’s physiological status to the nursing staff. When the software updates and resets these settings, it strips away the customized safety parameters that clinicians have carefully programmed for each individual patient or care area. This means that if a specific patient requires a heart rate limit of 100 beats per minute to trigger an alert, but the system reverts to a generic default, dangerous changes in the patient’s condition might go unnoticed until it is too late.
The individuals most vulnerable in this scenario are those who rely on continuous, real-time monitoring for their immediate safety. This typically includes patients in critical care units, post-operative recovery wards, or emergency departments where vital signs must be watched constantly. These patients may be sedated, intubated, or otherwise unable to communicate if they feel unwell. Their safety is entirely dependent on the central hub and viewer systems alerting nurses to abnormalities. If the software causes a loss of monitoring at these hubs, the delay in detection can lead to severe medical complications. There are no specific demographic exclusions mentioned in the recall facts (such as age or gender), but anyone receiving acute care in a facility using this software is potentially affected.
It is also important to note the distribution pattern of this device. The recall affects units distributed in several U.S. states, specifically Michigan and New York, as well as Wisconsin. However, it is not limited to the United States. The software has also been distributed to Australia, the Czech Republic, Finland, Germany, Italy, Netherlands, Qatar, Saudi Arabia, Switzerland, the United Arab Emirates, and the United Kingdom. If you or a loved one received care in any of these regions in a facility using GE Medical Systems infrastructure, there is a possibility that this specific software version was part of the monitoring system.
Because the remedy for this recall is not yet stated in the official FDA report, the risk period extends until healthcare providers can verify their systems and apply the necessary patches or updates. Until that happens, the vulnerability remains. The "risk" here is not about the device exploding or causing physical injury through malfunction, but rather the silent failure of a digital safety net. For patients who are critically ill, that silence can be dangerous. It underscores why this Class II recall is taken seriously by the FDA: it addresses a failure that could lead to serious adverse health consequences if the monitoring gap is not identified and corrected quickly.
For family members and caregivers of patients in these affected regions, the best course of action is awareness. You do not need to panic, but you should be attentive. If you notice any unusual behavior from medical staff or a lack of response to routine vital sign checks, it may be worth asking if there are any known technical issues with the monitoring systems at that facility. While you cannot fix the software yourself, your vigilance serves as an additional layer of safety for your loved one during this interim period.
How to tell if you have the recalled item
Identifying whether your equipment falls under this specific FDA recall requires a careful and methodical check of your device’s documentation and physical labels. Because this is a software-driven issue within a medical monitoring system, simply knowing that you own a GE Medical Systems product is not enough to determine if you are affected. You must verify the exact version of the software and the specific hardware serial numbers associated with the system. The recall targets a very precise configuration: PORTRAIT CORE SERVICES SOFTWARE V1.0.5, which is linked to Reference Number 5697353. If your system is running a different version or has a different reference number, it is not part of this specific safety alert.
To confirm if you have the recalled item, start by locating the Global Trade Item Number (GTIN) and the serial numbers on your equipment. The GTIN for this affected batch is 00195278364838. This number acts as a unique digital fingerprint for the product package and can often be found on the original shipping box, the purchase invoice, or the technical specification sheet provided during installation. However, the most critical identifiers are the serial numbers, as these pinpoint the exact units involved in the distribution. The recalled units include the following specific serial codes: SUC23080050TA, SUD22470001TA, SUD22420001TA, SUD22470010TA, SUD23390001TA, SUD23390003TA, SUD23390004TA, SUD23390009TA, SUD23390010TA, SUD22470009TA, SUD22470003TA, SUD22470004TA, SUD22470005TA, SUD23390005TA, and SUD22280002TA.
You should look for these serial numbers on the hardware tags attached to the PORTRAIT monitoring hubs or central viewer units. These labels are typically affixed to the back or side of the device chassis, near the power input or network ports. If you are a healthcare administrator or IT specialist responsible for multiple facilities, cross-reference your asset management logs against this list immediately. It is also important to note that while the primary distribution pattern includes the United States (specifically Michigan and New York) and Wisconsin, the recall extends internationally to Australia, the Czech Republic, Finland, Germany, Italy, the Netherlands, Qatar, Saudi Arabia, Switzerland, the United Arab Emirates, and the United Kingdom. If your facility is located in any of these regions and you cannot locate the physical serial number tags, contact your GE Medical Systems representative or check your internal procurement records for the Reference Number 5697353 to verify if your system was part of this specific shipment.
What to do — step by step
When you encounter a recall involving medical technology, the most important thing to remember is that you are not alone in navigating this process. The FDA classifies this as a Class II recall, which generally indicates a situation where temporary or medically reversible health consequences might occur, but where there is a reasonable probability that the hazard could cause serious adverse effects. Because the specific remedy for this PORTRAIT CORE SERVICES SOFTWARE issue has not been publicly stated by GE Medical Systems Information Technologies Inc., you cannot assume a standard return-to-manufacturer protocol applies here. Instead, your immediate priority must be establishing direct communication with the responsible parties to understand the exact corrective action required for your specific installation.
- Stop using the affected software configuration immediately if possible. The recall notice highlights that this software update can cause a loss of patient monitoring at the Hub and Central Viewer. It also resets all alarm settings to factory defaults, meaning any customized safety parameters you or your medical staff configured for specific patients or care areas are now gone. If you have recently updated to version 1.0.5 (Ref# 5697353) on any of the listed serial numbers, do not rely on the current alarm settings as they are no longer accurate. Treat the system as if it is providing false reassurance until further notice.
- Contact GE Medical Systems Information Technologies Inc. directly for instructions. Since the remedy is not stated in the public recall announcement, you must wait for official guidance from the manufacturer. Look for a dedicated recall hotline or email address on the official FDA recall database entry or any direct communication you may have received. Do not attempt to reinstall previous versions of the software on your own without explicit instruction, as this could interfere with other critical system components or void warranties.
- Verify your serial numbers against the recall list. The recall affects specific units with GTIN 00195278364838 and a precise list of serial numbers, including SUC23080050TA, SUD22470001TA, and others ending in TA. Check your facility’s asset management logs carefully. If you are outside the United States (in countries like Germany, the UK, or Australia), ensure you are contacting the local authorized representative for GE Medical Systems in your region, as support channels may differ from those in Wisconsin or New York.
- Implement manual monitoring protocols while waiting for resolution. Because the software failure can lead to a loss of monitoring, you must immediately revert to manual observation methods for any patients connected to or monitored by these systems. Ensure that nursing and clinical staff are aware that electronic alarms may not function as expected and that visual checks are now the primary safety method. Document this deviation in your facility’s risk management logs.
- Keep detailed records of all interactions. Save every email, note every phone call time and representative name, and keep copies of any shipping labels or return instructions you receive. This documentation is crucial for liability purposes and ensures that if the remedy involves a refund, repair, or replacement, you have proof of your compliance with the recall.
Your refund, repair, or replacement options
When you encounter a medical device recall, the most immediate question is often, "What happens next?" In this specific case involving GE Medical Systems Information Technologies Inc., the situation requires a moment of calm clarity. The official FDA recall record for PORTRAIT CORE SERVICES SOFTWARE V1.0.5 (Ref# 5697353) currently does not list a specific remedy. This means that, at this time, the public notice has not detailed whether you will receive a refund, a software patch to repair the issue, or a hardware replacement unit. It is important to understand that "not stated" in a recall document does not mean there is no solution; rather, it indicates that the specific logistical steps for resolving the issue have not yet been published in this particular announcement. Manufacturers often release initial hazard warnings before finalizing the distribution of updated software or replacement kits, so the absence of these details right now is a temporary state rather than a permanent lack of recourse.
Because the hazard involves critical patient monitoring failures and the resetting of alarm settings to factory defaults, the remedy will likely be technical rather than financial. In cases of software-based recalls for medical hubs and central viewers, manufacturers typically provide a corrected software update or a configuration script that restores the proper alarm parameters without wiping patient-specific data. However, since the official record does not specify this, you should not assume any automatic action is being taken on your end. You are responsible for verifying the status of your device with the manufacturer directly. Do not attempt to download updates from unofficial sources or third-party websites, as these may contain malware or incorrect code that could exacerbate the monitoring loss.
To find out what options are available to you—whether that is a free software patch, a service call, or other corrective measures—you must contact GE Medical Systems Information Technologies Inc. directly. The recall notice does not provide specific phone numbers, email addresses, or web portal links in this text, so you will need to locate the official customer support channels for GE Healthcare’s medical information technology division. When you reach out, have your device’s serial number ready. The affected units include those with serial numbers such as SUC23080050TA, SUD22470001TA, and others listed in the distribution pattern. Providing this exact information will allow their support team to verify if your specific unit is part of the recalled batch and guide you through the next steps. They may instruct you to schedule a technician visit or provide instructions for applying a manual update.
If you are an administrator or clinician responsible for these systems, do not wait for the remedy details to appear in future press releases. The risk of lost patient monitoring data is immediate and serious. Reach out to GE Medical Systems today to inquire about the remediation process. Ask specifically if they have released a Field Service Bulletin (FSB) or a Notice to Repair that is not yet included in this initial FDA recall summary. By taking proactive steps to contact the manufacturer, you ensure that your facility’s compliance with safety standards is maintained and that patient care is not compromised by outdated or faulty software configurations.